Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells

Viswanathan Natarajan, William M. Scribner, Andrew J. Morris, Shukla Roy, Suryanarayana Vepa, Jianbin Yang, Raj Wadgaonkar, Sekhar P.M. Reddy, Joe G.N. Garcia, Narasimham L. Parinandi

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

We previously demonstrated that diperoxovanadate (DPV), a synthetic peroxovanadium compound and cell-permeable oxidant that acts as a protein tyrosine phosphatase inhibitor and insulinomimetic, increased phospholipase D (PLD) activation in endothelial cells (ECs). In this report, the regulation of DPV-induced PLD activation by mitogen-activated protein kinases (MAPKs) was investigated. DPV activated extracellular signal-regulated kinase, c-Jun NH2-terminal kinase (JNK), and p38 MAPK in a dose- and time-dependent fashion. Treatment of ECs with p38 MAPK inhibitors SB-203580 and SB-202190 or transient transfection with a p38 dominant negative mutant mitigated the PLD activation by DPV but not by phorbol ester. SB-202190 blocked DPV-mediated p38 MAPK activity as determined by activated transcription factor-2 phosphorylation. Immunoprecipitation of PLD from EC lysates with PLD1 and PLD2 antibodies revealed both PLD isoforms associated with p38 MAPK. Similarly, PLD1 and PLD2 were detected in p38 immunoprecipitates from control and DPV-challenged ECs. Binding assays demonstrated interaction of glutathione S-transferase-p38 fusion protein with PLD1 and PLD2. Both PLD1 and PLD2 were phosphorylated by p38 MAPK in vitro, and DPV increased phosphorylation of PLD1 and PLD2 in vivo. However, phosphorylation of PLD by p38 failed to affect PLD activity in vitro. These results provide evidence for p38 MAPK-mediated regulation of PLD in ECs.

Original languageEnglish (US)
Pages (from-to)L435-L449
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume281
Issue number2 25-2
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Keywords

  • Peroxovanadate
  • Phospholipase D
  • Phosphorylation
  • Reactive oxygen species
  • Vascular endothelium
  • p38 mitogen-activated protein kinase

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Fingerprint Dive into the research topics of 'Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells'. Together they form a unique fingerprint.

  • Cite this

    Natarajan, V., Scribner, W. M., Morris, A. J., Roy, S., Vepa, S., Yang, J., Wadgaonkar, R., Reddy, S. P. M., Garcia, J. G. N., & Parinandi, N. L. (2001). Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. American Journal of Physiology - Lung Cellular and Molecular Physiology, 281(2 25-2), L435-L449. https://doi.org/10.1152/ajplung.2001.281.2.l435